The role of group 3 innate lymphoid cell in intestinal disease

Group 3 innate lymphoid cells (ILC3s), a novel subpopulation of lymphocytes enriched in the intestinal mucosa, are currently considered as key sentinels in maintaining intestinal immune homeostasis. ILC3s can secrete a series of cytokines such as IL-22 to eliminate intestinal luminal antigens, promo...

Full description

Bibliographic Details
Main Authors: Minghui Li, Zehui Wang, Wei Jiang, Yihan Lu, Jun Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1171826/full
_version_ 1797847140933828608
author Minghui Li
Zehui Wang
Wei Jiang
Yihan Lu
Jun Zhang
author_facet Minghui Li
Zehui Wang
Wei Jiang
Yihan Lu
Jun Zhang
author_sort Minghui Li
collection DOAJ
description Group 3 innate lymphoid cells (ILC3s), a novel subpopulation of lymphocytes enriched in the intestinal mucosa, are currently considered as key sentinels in maintaining intestinal immune homeostasis. ILC3s can secrete a series of cytokines such as IL-22 to eliminate intestinal luminal antigens, promote epithelial tissue repair and mucosal barrier integrity, and regulate intestinal immunity by integrating multiple signals from the environment and the host. However, ILC3 dysfunction may be associated with the development and progression of various diseases in the gut. Therefore, in this review, we will discuss the role of ILC3 in intestinal diseases such as enteric infectious diseases, intestinal inflammation, and tumors, with a focus on recent research advances and discoveries to explore potential therapeutic targets.
first_indexed 2024-04-09T18:06:23Z
format Article
id doaj.art-1af3150d2ae846c786175670ea8f56e2
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-09T18:06:23Z
publishDate 2023-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-1af3150d2ae846c786175670ea8f56e22023-04-14T05:36:49ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-04-011410.3389/fimmu.2023.11718261171826The role of group 3 innate lymphoid cell in intestinal diseaseMinghui LiZehui WangWei JiangYihan LuJun ZhangGroup 3 innate lymphoid cells (ILC3s), a novel subpopulation of lymphocytes enriched in the intestinal mucosa, are currently considered as key sentinels in maintaining intestinal immune homeostasis. ILC3s can secrete a series of cytokines such as IL-22 to eliminate intestinal luminal antigens, promote epithelial tissue repair and mucosal barrier integrity, and regulate intestinal immunity by integrating multiple signals from the environment and the host. However, ILC3 dysfunction may be associated with the development and progression of various diseases in the gut. Therefore, in this review, we will discuss the role of ILC3 in intestinal diseases such as enteric infectious diseases, intestinal inflammation, and tumors, with a focus on recent research advances and discoveries to explore potential therapeutic targets.https://www.frontiersin.org/articles/10.3389/fimmu.2023.1171826/fullinnate lymphoid cellintestinal immunityinflammatory bowel diseasecolorectal cancerimmune therapyplasticity
spellingShingle Minghui Li
Zehui Wang
Wei Jiang
Yihan Lu
Jun Zhang
The role of group 3 innate lymphoid cell in intestinal disease
Frontiers in Immunology
innate lymphoid cell
intestinal immunity
inflammatory bowel disease
colorectal cancer
immune therapy
plasticity
title The role of group 3 innate lymphoid cell in intestinal disease
title_full The role of group 3 innate lymphoid cell in intestinal disease
title_fullStr The role of group 3 innate lymphoid cell in intestinal disease
title_full_unstemmed The role of group 3 innate lymphoid cell in intestinal disease
title_short The role of group 3 innate lymphoid cell in intestinal disease
title_sort role of group 3 innate lymphoid cell in intestinal disease
topic innate lymphoid cell
intestinal immunity
inflammatory bowel disease
colorectal cancer
immune therapy
plasticity
url https://www.frontiersin.org/articles/10.3389/fimmu.2023.1171826/full
work_keys_str_mv AT minghuili theroleofgroup3innatelymphoidcellinintestinaldisease
AT zehuiwang theroleofgroup3innatelymphoidcellinintestinaldisease
AT weijiang theroleofgroup3innatelymphoidcellinintestinaldisease
AT yihanlu theroleofgroup3innatelymphoidcellinintestinaldisease
AT junzhang theroleofgroup3innatelymphoidcellinintestinaldisease
AT minghuili roleofgroup3innatelymphoidcellinintestinaldisease
AT zehuiwang roleofgroup3innatelymphoidcellinintestinaldisease
AT weijiang roleofgroup3innatelymphoidcellinintestinaldisease
AT yihanlu roleofgroup3innatelymphoidcellinintestinaldisease
AT junzhang roleofgroup3innatelymphoidcellinintestinaldisease